Digital Diagnostics

United States - Coralville, Iowa

• 23/08/2022
• Series B
• $75,000,000

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare.

Related People

John BertrandFounder

United States - San Francisco, California

John Bertrand is the CEO of Digital Diagnostics, a pioneering AI diagnostics company on a mission to transform the accessibility, affordability, equity, and quality of healthcare. Bertrand is an experienced business leader at the cross-section of healthcare and technology. Through his 15+ years in the healthcare technology industry, he has developed expertise in identifying market opportunities, creating new products, pivoting existing businesses, and building strong teams.

John Bertrand’s career began at Epic, a healthcare software company. There Bertrand led cross-functional teams in a variety of product, customer success, and business development roles with a focus on growth. He later served as Executive in Residence at 8VC, a venture capital firm focused on healthcare technology. His time in this space focused on the application of artificial intelligence and computer vision in healthcare.

LinkedIn https://www.linkedin.com/in/john-bertrand-b193094/